SCHEMBL561587

SCHEMBL561587

CC(=CC(=O)C(F)(F)F)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP2C9 P11712 1/20 0.32
PTGS1 P23219 1/20 0.32
AKR1C3 P42330 1/20 0.32
NR4A1 P22736 1/20 0.31
NR4A2 P43354 1/20 0.31
NR4A3 Q92570 1/20 0.31
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL881148 0.79 MAPT (0.46) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL31678384 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL29424301 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL29424246 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL31516170 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL31678235 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL31236855 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL16337476 0.77 TSHR (0.36) MAPTALDH1A1CYP2C9PTGS1AKR1C3
SCHEMBL31678395 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3
SCHEMBL30633891 0.77 MAPT (0.44) MAPTALDH1A1NR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563273-B1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEV LLC (US) 2017-08-23 EP claimed
US-9539087-B2 Intravitreous self adaptive stent EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-01-10 US claimed
EP-2563273-A1 INTRAVITREOUS SELF ADAPTIVE STENT Empire Technology Development LLC (US) 2013-03-06 EP claimed
US-20120035738-A1 INTRAVITREOUS SELF ADAPTIVE STENT CRESTLINE DIRECT FINANCE, L.P. 2012-02-09 US claimed
WO-2011134146-A1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2011-11-03 WO claimed
US-20070073016-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2007-03-29 US claimed
US-7115691-B2 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION (US) 2006-10-03 US claimed
US-20040059408-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2004-03-25 US claimed
US-6653426-B2 Radially expandable; coaxial polymer comprising pentafluoropropyl acrylate and (heptadecyl fluorodecyl methacrylate) comonomers QUANAM MEDICAL CORPORATION 2003-11-25 US claimed
US-20030149470-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2003-08-07 US claimed
US-6530950-B1 Radially expandable; rigid and flexible regions; polymer of such as pentafluoropropyl acrylate, polyethylene glycol methacrylate and methylmethacrylate QUANAM MEDICAL CORPORATION 2003-03-11 US claimed
EP-1140242-B1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORP (US) 2002-10-30 EP claimed
EP-1140242-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT Quanam Medical Corporation (US) 2001-10-10 EP claimed
WO-2000041738-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORPORATION (US) 2000-07-20 WO claimed
US-9980806-B2 Shape memory tubular stent with grooves BOSTON SCIENTIFIC SCIMED, INC. (US) 2018-05-29 US disclosed
EP-2563273-B1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEV LLC (US) 2017-08-23 EP disclosed
US-9539087-B2 Intravitreous self adaptive stent EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-01-10 US disclosed
EP-1140242-B1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORP (US) 2002-10-30 EP disclosed
EP-1140242-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT Quanam Medical Corporation (US) 2001-10-10 EP disclosed
WO-2000041738-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORPORATION (US) 2000-07-20 WO disclosed